Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
6,776 total articles
Coca-Cola Consolidated announced a $35 million investment to add a new glass bottle production line at its Indianapolis facility, expected to begin construction in late 2026. The expansion will create 15 to 20 new full-time jobs and boost local economic activity. This reinforces Indianapolis as a key production hub within the Coca-Cola System and e…
Robin Energy Ltd., a NASDAQ-listed international ship-owner specializing in energy transportation, has sold its 2006-built Handysize tanker vessel, M/T Wonder Mimosa, for $12.8 million. The sale was finalized on April 29, 2026, and is expected to generate a net gain of approximately $6.7 million during Q2 2026. Following this transaction, Robin Ene…
Natural Alternatives International, Inc. has expanded the applications of its advanced carnosine booster, TriBsyn®, across ready-to-drink (RTD) beverages, protein drinks, dairy products, gummies, and medical nutrition. This extension aligns with growing consumer demand for convenient and effective wellness products. TriBsyn® is clinically supported…
Oncolytics Biotech announced promising data from its REO 022 study showing that the investigational immunotherapy pelareorep yielded a median duration of response of 19.5 months in second-line KRAS-mutant MSS metastatic colorectal cancer patients, a 3-4 times improvement over the historical 4-6 months benchmark. The company is engaged with the FDA …
The Vita Coco Company has partnered with adventure brand Baboon to the Moon to launch a limited-edition luggage capsule called the Sweet Escape Essentials collection, inspired by the new Frosted Lemonade flavor of Vita Coco Treats coconutmilk-based beverages. The collection features travel bags and accessories in a lemony yellow design and aims to …
Fate Therapeutics announced data presentations for its off-the-shelf CAR T-cell therapy candidates FT819, FT839, and FT836 at the 2026 ASGCT Annual Meeting. These therapies target various cancers and autoimmune diseases with novel mechanisms and without the need for conditioning chemotherapy, highlighting advancements in cellular immunotherapies.
Turtle Beach Corporation announced the closing of a new credit structure comprising an $80 million revolving asset-based lending facility and an $85 million term loan, replacing its prior $150 million credit agreement. This restructuring is designed to enhance financial flexibility and enable the company to accelerate its capital return strategy, i…
Foxx Development Holdings Inc. has regained compliance with Nasdaq's minimum market value of listed securities requirement after previously falling below the threshold. Nasdaq confirmed the company's market value met the required $35 million minimum for 15 consecutive business days, ensuring continued listing on the Nasdaq Capital Market. The compa…
Nexxen, a Nasdaq-traded adtech platform, announced an exclusive partnership with ADvolution, a fandom intelligence provider, to integrate culturally informed audience segments into Nexxen's demand-side platform. This collaboration enables political advertisers to programmatically reach voters influenced by social media personalities by combining tr…
Quantum X Labs Inc. has filed a U.S. patent application covering a novel compact atomic clock utilizing advanced quantum technology to enhance precision. This innovation aims to deliver laboratory-grade performance in deployable, commercial-ready solutions for aerospace, defense, financial institutions, and critical infrastructure requiring high-pr…
Gyre Therapeutics, a Nasdaq-listed biopharmaceutical company focused on fibrosis therapies, has completed the acquisition of clinical-stage Cullgen Inc. in an all-stock deal valued at approximately $300 million. The combined entity now features a commercial asset in China (ETUARY®) and an expanded pipeline including targeted protein degraders and d…
Polyrizon Ltd., a biotech company specializing in intranasal hydrogels, announced the submission of amended claims in its U.S. patent application to broaden protection for its proprietary intranasal drug delivery platform. The expanded claims now cover drug delivery systems and methods of use designed to improve drug residence time and absorption i…
Liquidia Corporation, a Nasdaq-listed biopharmaceutical company focused on respiratory and vascular disease therapies, announced it will report its first quarter 2026 financial results on May 11, 2026, accompanied by a live webcast. The company is known for its PRINT Technology and products like YUTREPIA for pulmonary hypertension and is developing…
NeoVolta Inc., a U.S.-based energy storage technology company, announced it will release its Q3 fiscal 2026 earnings after market close on May 14, 2026, followed by a conference call on May 15 to discuss financial results, operational progress, and strategic priorities.
Fortress Biotech announced that its CEO, Lindsay A. Rosenwald, M.D., will participate in a fireside chat at the upcoming H.C. Wainwright 2nd Annual Royalty Company Virtual Conference. The company highlights its biopharmaceutical portfolio and strategic partnerships in advancing product opportunities across oncology, dermatology, and rare diseases.
NewtekOne, Inc.'s banking subsidiary, Newtek Bank, N.A., announced it now supports instant payments through the Federal Reserve's FedNow® Service and The Clearing House's RTP® network, offering commercial clients real-time payment access any time of day. This service integrates with Newtek's online business portal and zero-fee accounts to provide f…
Firefly Aerospace, through its wholly owned subsidiary SciTec, has received an Other Transaction Authority agreement from the U.S. Space Force to support the development of the Space-Based Interceptor under the Golden Dome architecture, a critical missile defense program slated for demonstration by 2028. This contract is part of a larger $3.2 billi…
Satellogic, Inc. announced the hiring of three senior defense and intelligence industry veterans to its global sales force amid accelerating demand for persistent, sovereign geospatial intelligence by government customers worldwide. The new hires bring decades of experience and strengthen Satellogic's capabilities to secure programmatic partnership…
Fiserv's April 2026 Small Business Index shows that U.S. small business sales growth was sustained primarily by higher prices rather than increased demand, with foot traffic declining. Categories such as restaurants experienced softness, while gas station sales grew sharply due to rising fuel costs. Consumers are moderating spending, favoring value…
Bicara Therapeutics, a clinical-stage biopharmaceutical company focused on bifunctional therapies targeting solid tumors, announced its plan to report first quarter 2026 financial results and business updates on May 11, 2026. The company will host a conference call and webcast to discuss progress, particularly relating to its lead candidate ficeraf…
Research Frontiers Inc., a Nasdaq-listed technology company specializing in SPD-Smart light-control film technology, announced it will release its Q1 2026 financial results on May 7, 2026, followed by a conference call led by its CEO Joseph M. Harary to discuss financial and operating results as well as recent company developments.
FibroBiologics has released the first cGMP-compliant batch of its investigational drug CYWC628 designed for treating diabetic foot ulcers (DFUs). This release enables the commencement of a Phase 1/2 clinical trial to evaluate the safety, tolerability, and preliminary efficacy of CYWC628. The milestone represents progress in the company’s developmen…
DeFi Development Corp., traded as DFDV on Nasdaq, unveiled a $200 million at-the-market equity facility to acquire more Solana (SOL) tokens and support operational and strategic initiatives. The company implements a treasury strategy focused on accumulating SOL, staking it through its own validator infrastructure for rewards, and engaging in decent…
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company specializing in cell and gene therapies, announced its first quarter 2026 financial results conference call to be held on May 13, 2026. The company highlighted its commercial product ZEVASKYN, a gene therapy for recessive dystrophic epidermolysis bullosa, and its ongoing pipelin…
Dentsply Sirona has introduced Smart View - Detect, the world's first FDA-cleared AI-enabled diagnostic aid designed to enhance the detection of teeth affected by periapical radiolucencies (PARLs) in CBCT scans. This AI support feature increases detection sensitivity by approximately 46%, supports efficient review of complex dental imaging data, an…
